Support Blood Sugar Control : GLP-1 injections stabilize blood sugar by increasing insulin and lowering glucagon, which also helps reduce cravings
This is off-label and should involve discussion with a doctor
KPV has been studied in models of inflammatory bowel disease (DSS- and TNBS-induced colitis), contact dermatitis, cutaneous vasculitis, asthma, rheumatoid arthritis, and ocular inflammation
Our findings clearly lend support to the use of GLP-1 agonists in combination with basal insulin in the clinical management of patients with type 2 diabetes. Victoria Ruszala, a diabetes pharmacist at North Bristol NHS Trust, said that the study provided reassurance about the co-prescription of GLP-1 agonists and basal insulin, already widely practised and endorsed by expert bodies such as the Association of British Clinical Diabetologists
Retatrutide trials have explored various dosing strategies, with optimal dosing still being determined through ongoing research